Point Of Care Test Market - Forecast(2024 - 2030)

Report Code: HCR 53332 Report Format: PDF + Excel

Point Of Care Test Market Overview

Point Of Care Test Market size was estimated at $21.3 billion in 2020 and is projected to grow at a CAGR of 3.6% during the forecast period 2021-2026. Point Of Care Test is the diagnostic test that is done with the help of electronic and non-electronic devices. Point Of Care Test provide rapid detection and information for patient care at the time and site. It is performed for rapid detection of electronic health records, oxygen saturation, acute coronary syndrome, carpal tunnel syndrome. 

Point Of Care Test is performed outside of laboratory and near patient site. It can be used for self-testing such pregnancy test kit and glucose monitoring kit. Increasing prevalence of chronic diseases such as diabetes, cancer, heart diseases and infectious diseases coupled with rising aging population is major factor driving the growth of the market. Moreover, growing demand for Point Of Care Test for easy and fast detection of diseases further enhance the overall market demand for Point Of Care Test during the aforesaid period.

Point Of Care Test Market  Report Coverage

The report: “Point Of Care Test Market – Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Point Of Care Test Market:

By Product Type: Pregnancy & Fertility Testing Kit, Infectious Disease Testing Kit, Cholesterol Test Strip, Glucose Monitoring Kit, Cardio-metabolic monitoring kits, Hematology Testing Kit,  Urinalysis Testing Kits, Tumor/Cancer Markers Testing Kits
By Prescription Mode: prescription-based testing, Over-the-counter (OTC) testing
By End-User: Hospitals/Clinics, Home Care, Research Laboratories, Outpatient Healthcare & Ambulatory Care Setting.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Others), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand and Others), South America(Brazil, Argentina and others), and Rest of the World (Middle East and Africa)

Key Takeaways

  • In 2020, North America dominated the Point Of Care Test Market owing to rising incidence of chronic diseases.
  • Increasing innovation and development in Point Of Care Test across the globe is driving the market growth of Point Of Care Test.
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Point Of Care Test Market report.
  • High cost of point of care testing devices and stringent regulatory policies are challenging the growth of the market.



Point Of Care Test Market Segment Analysis- By Product Type

Based on the drug class, Point Of Care Test Market is segmented into Pregnancy & Fertility Testing Kit, Infectious Disease Testing Kit, Cholesterol Test Strip, Glucose Monitoring Kit, Cardio-metabolic monitoring kits, Hematology Testing Kit, Urinalysis Testing Kits, Tumor/Cancer Markers Testing Kits.  The Glucose Monitoring Kit segment is estimated to dominate the market during the period 2021-2026. This is attributed to rising prevalence of diabetes across the globe. According to, World Health Organization (WHO), around 422 million people worldwide are suffering from diabetes and it causes 1.6 million deaths per year. The Infectious Disease Testing Kit, segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 3.0% during the period 2021-2026. This is mainly owing to growing infectious diseases across the globe.

Point Of Care Test Market Segment Analysis- By End User

Based on the end user, Point Of Care Test Market is segmented into Hospitals/Clinics, Home Care, Research Laboratories, Outpatient Healthcare & Ambulatory Care Settings. In 2020, Hospitals/Clinics is estimated to hold major share in the market. This is mainly rising number of hospitals and clinics that leads to reduction in waiting time with the use of rapid point of care test. Moreover, chronic diseases patient require long term care and daily monitoring in hospitals also contributing to the dominance of this segment. Also, Outpatient Healthcare & Ambulatory Care Settings is projected to grow with a CAGR of 2.6% over the period 2021-2026. This is owing to the most convenient and proper care and monitoring of patient for faster recovery by providing electronic health records, oxygen saturation.

Point Of Care Test Market Segment Analysis- By Geography

North America dominated the Point Of Care Test market share accounting for 42% of the market in 2020. This is mainly owing to increasing prevalence of chronic diseases such as cancer, diabetes and others in this region. According to, Centres for Disease Control and Prevention (CDC), in U.S. more than 100 million adults are suffering from diabetes or prediabetes. However, the Asia-Pacific region is projected to be the fastest-growing over the period 2021-2026. This is owing to rising expenditure on healthcare coupled with rising aging population.

Point Of Care Test Market Drivers

Increasing Prevalence of Chronic Diseases

Increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases and others across the globe is driving the growth of Point Of Care Test market. According to World Health Organization (WHO), deaths caused by chronic diseases are more than 38 million per year across the globe. Cardiovascular diseases account most deaths (17.9 million), followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). Moreover, increasing geriatric populations is also set to increase the market growth.

Rising Research and Development

Increase in research and development of advanced technology for Point Of Care Test is also driving the market. New product development and innovation in formulations and test kit designing in Point Of Care Test for instance, in 2019, Abbott launched Afinion HbA1c Dx assay, first rapid point of care kit for diabetes. Also, rising adoption of novel technologies for self testing and home care is also set to the growth of Point Of Care Test Market.

Point Of Care Test Market Challenges

High cost of point of care testing devices and stringent regulatory policies also reimbursement issues is challenging the market. Along with this product recall by major players are also further challenging the growth of the market.

Covid-19 Impact

Moreover, the outbreak of COVID-19 around the world has impacted all industries including healthcare industry. Covid- 19 affects the Point Of Care Test market including shortage of laboratory based molecular assay owing to less supply of POC test kits. Also owing to increase in number of COVID-19 the usage of POC test increases that diagnose the COVID-19. These affects Point Of Care Test market by cancellation of scheduled visit for primary care at hospitals and reflecting patients concern about infection.

Point Of Care Test Market Landscape

Product launches, Merger & Acquisitions, Joint Ventures and R&D activities are key strategies adopted by players in the Point Of Care Test Market. Point Of Care Test top 10 companies are Abbott Laboratories, Johnson & Johnson, Siemens Healthineers, Roche Diagnostics, AccuBioTech, Nova Biomedical, Lifescan Inc., Becton, Dickenson and Company (BD), Thermofisher Scientific and Danaher Corporation.

Developments

In June 2019, Abbott launched Afinion HbA1c Dx assay, first rapid point of care kit for diabetes. The product is approved by FDA.

Relevant Reports:

Report Code: HCR 0528

Report Code:  HCR 0198

For more Lifesciences and Healthcare Market reports, please click here

1. Point Of Care Test Market - Overview
    1.1 Definitions and Scope
2. Point Of Care Test Market - Executive Summary
    2.1 Market Revenue and Key Trends
    2.2 Key trends by Product Type
    2.3 Key trends by Prescription Mode
    2.4 Key trends by End User
    2.5 Key trends by Geography
3. Point Of Care Test Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis –
    3.5 Pricing Analysis
4. Point Of Care Test Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Point Of Care Test Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Point Of Care Test Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Point Of Care Test Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Point Of Care Test Market – By Product Type(Market Size –$Million/$Billion)
    8.1 Pregnancy & Fertility Testing Kit
    8.2 Infectious Disease Testing Kit
    8.3 Cholesterol Test Strip
    8.4 Glucose Monitoring Kit
    8.5 Cardio-metabolic monitoring kits
    8.6 Hematology Testing Kit
    8.7 Urinalysis Testing Kits
    8.8 Tumor/Cancer Markers Testing Kits
9. Point Of Care Test Market - By Application(Market Size –$Million/$Billion)
    9.1 Prescription-based Testing
    9.2 Over-the-counter(OTC) Testing
10. Point Of Care Test Market - By End-User(Market Size –$Million/$Billion)
    10.1 Hospital/ Clinics
    10.2 Home Care
    10.3 Research Laboratories
    10.4 Outpatient Healthcare & Ambulatory Care Settings
11. Point Of Care Test Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Others
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Point Of Care Test Market - Entropy
13. Point Of Care Test Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Point Of Care Test Market – Key Company List by Country Premium Premium
15. Point Of Care Test Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global EUROPE POINT OF CARE TEST MARKET, BY END USERS Market 2023-2030 ($M)
1.1 HOSPITALS Market 2023-2030 ($M) - Global Industry Research
1.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Global Industry Research
2.Global EUROPE POINT OF CARE TEST MARKET, BY END USERS Market 2023-2030 (Volume/Units)
2.1 HOSPITALS Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 DIAGNOSTIC CENTRES Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America EUROPE POINT OF CARE TEST MARKET, BY END USERS Market 2023-2030 ($M)
3.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
3.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
4.South America EUROPE POINT OF CARE TEST MARKET, BY END USERS Market 2023-2030 ($M)
4.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
4.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
5.Europe EUROPE POINT OF CARE TEST MARKET, BY END USERS Market 2023-2030 ($M)
5.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
5.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
6.APAC EUROPE POINT OF CARE TEST MARKET, BY END USERS Market 2023-2030 ($M)
6.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
6.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
7.MENA EUROPE POINT OF CARE TEST MARKET, BY END USERS Market 2023-2030 ($M)
7.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
7.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Point Of Care Test Market Revenue, 2023-2030 ($M)
2.Canada Point Of Care Test Market Revenue, 2023-2030 ($M)
3.Mexico Point Of Care Test Market Revenue, 2023-2030 ($M)
4.Brazil Point Of Care Test Market Revenue, 2023-2030 ($M)
5.Argentina Point Of Care Test Market Revenue, 2023-2030 ($M)
6.Peru Point Of Care Test Market Revenue, 2023-2030 ($M)
7.Colombia Point Of Care Test Market Revenue, 2023-2030 ($M)
8.Chile Point Of Care Test Market Revenue, 2023-2030 ($M)
9.Rest of South America Point Of Care Test Market Revenue, 2023-2030 ($M)
10.UK Point Of Care Test Market Revenue, 2023-2030 ($M)
11.Germany Point Of Care Test Market Revenue, 2023-2030 ($M)
12.France Point Of Care Test Market Revenue, 2023-2030 ($M)
13.Italy Point Of Care Test Market Revenue, 2023-2030 ($M)
14.Spain Point Of Care Test Market Revenue, 2023-2030 ($M)
15.Rest of Europe Point Of Care Test Market Revenue, 2023-2030 ($M)
16.China Point Of Care Test Market Revenue, 2023-2030 ($M)
17.India Point Of Care Test Market Revenue, 2023-2030 ($M)
18.Japan Point Of Care Test Market Revenue, 2023-2030 ($M)
19.South Korea Point Of Care Test Market Revenue, 2023-2030 ($M)
20.South Africa Point Of Care Test Market Revenue, 2023-2030 ($M)
21.North America Point Of Care Test By Application
22.South America Point Of Care Test By Application
23.Europe Point Of Care Test By Application
24.APAC Point Of Care Test By Application
25.MENA Point Of Care Test By Application
26.ALIGENT TECHNOLOGIES, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.F. HOFFMANN LA ROCHE LTD, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.AFFYMETRIX INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.ALERE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.LIFESCAN INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.BECTON, DICKENSON AND COMPANY, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.DANAHAR CORPORATION, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.BIOMERIEUX S.A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.NOVA BIOMEDICAL, Sales /Revenue, 2015-2018 ($Mn/$Bn)